You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
鐘南山:體外研究發現白雲山複方板藍根顆粒對新冠病毒有效
阿思達克 10-16 09:43
「粵澳呼吸道病原體新藥聯合研究中心」第四次理事會白雲山板藍根澳門轉化研討會暨合作簽約儀式在廣州舉行。據《南方日報》引述國家衛健委高級別專家組組長、中國工程院院士鐘南山參會時透露,研究團隊開展了一系列體外研究發現,白雲山複方板藍根顆粒對新冠病毒有效。

白雲山板藍根、白雲山複方板藍根科研成果計劃在澳門產業化,成為廣藥集團澳門國際總部成立後首個落地項目。該項目將由鍾南山擔任首席科學家,領導團隊開展白雲山板藍根研究成果的快速、高效轉化。(ta/k)

~

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account